-transparent.png){kind=logo}
Eight patients with Ph1-positive chronic myelogenous leukemia (CML) in chronic or accelerated phase received high-dose cyclophosphamide, total body irradiation, and bone marrow transplantation from an HLA-identical sibling donor. All patients had prompt engraftment and achieved complete hematologic remission. Six patients remain alive and in continuous remission with a normal bone marrow karyotype 3-20+ mo posttransplant. One patient died from cytomegalovirus interstitial pneumonitis. Only one patient who was transplanted in accelerated phase relapsed 6.5 mo posttransplant and died in blast crisis. High-dose combined modality therapy is capable of producing sustained complete remissions in patients with CML treated during chronic or accelerated phase.
R Champlin, and
W Ho, and
E Arenson, and
R P Gale
January 2002,
Journal of pediatric hematology/oncology,
R Champlin, and
W Ho, and
E Arenson, and
R P Gale
July 1998,
Bone marrow transplantation,
R Champlin, and
W Ho, and
E Arenson, and
R P Gale
January 1992,
Acta haematologica,
R Champlin, and
W Ho, and
E Arenson, and
R P Gale
July 1993,
Leukemia,
R Champlin, and
W Ho, and
E Arenson, and
R P Gale
January 1984,
Blood,
R Champlin, and
W Ho, and
E Arenson, and
R P Gale
July 1987,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R Champlin, and
W Ho, and
E Arenson, and
R P Gale
December 1986,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
R Champlin, and
W Ho, and
E Arenson, and
R P Gale
March 1984,
Lancet (London, England),
R Champlin, and
W Ho, and
E Arenson, and
R P Gale
July 1992,
Cancer genetics and cytogenetics,
R Champlin, and
W Ho, and
E Arenson, and
R P Gale
May 1990,
American journal of hematology,
